
    
      This is a multicenter, prospective, single-arm study. The primary tolerability endpoint will
      be evaluated up to 30-days post-operatively. Secondary endpoints will be evaluated at
      6-months. Extended follow-up will be conducted at 12-months, 24-months, and 36-months.
    
  